2 weeks Ago By Defense World Staff
Volatility & Risk Mangoceuticals has a beta of 2.08, suggesting that its stock price is 108% more volatile than the S&P 500. Comparatively, Mangoceuticals’ competitors have a beta of 3.
73, suggesting that their average stock price is 273% more volatile than the S&P 500. Insider & Institutional Ownership 56.7% of Mangoceuticals shares are held by institutional investors.
Comparatively, 61.8% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 39.
3% of Mangoceuticals shares are held by company insiders. Comparatively, 28.0% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders.
Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Profitability This table compares Mangoceuticals and its competitors’ net margins, return on equity and return on assets. Earnings & Valuation Mangoceuticals’ competitors have higher revenue and earnings than Mangoceuticals.
Mangoceuticals is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry. Summary Mangoceuticals competitors beat Mangoceuticals on 8 of the 9 factors compared. About Mangoceuticals ( Get Free Report ) Mangoceuticals, Inc.
develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.
com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program.
The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Receive News & Ratings for Mangoceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mangoceuticals and related companies with MarketBeat.com's FREE daily email newsletter ..
